tiprankstipranks
Trending News
More News >
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market
Advertisement

Cue Biopharma (CUE) Technical Analysis

Compare
621 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Cue Biopharma Inc’s (CUE) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Cue Biopharma Inc is a Buy.
Cue Biopharma Inc’s (CUE) 20-Day exponential moving average is 0.74, while Cue Biopharma Inc’s (CUE) share price is $0.71, making it a Sell.
Cue Biopharma Inc’s (CUE) 50-Day exponential moving average is 0.76, while Cue Biopharma Inc’s (CUE) share price is $0.71, making it a Sell.

Cue Biopharma (CUE) Pivot Points

Sep 29, 2025, 12:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.64
0.66
0.67
0.69
0.71
0.73
0.74
Fibonacci
0.66
0.67
0.68
0.69
0.71
0.71
0.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cue Biopharma (CUE) Moving Averages

Sep 29, 2025, 12:02 AM
Period
Simple
Exponential
MA5
0.70Buy
0.71Buy
MA10
0.71Sell
0.72Sell
MA20
0.74Sell
0.74Sell
MA50
0.79Sell
0.76Sell
MA100
0.75Sell
0.79Sell
MA200
0.92Sell
0.94Sell
Cue Biopharma Inc’s (CUE) 10-Day exponential moving average is 0.72, while Cue Biopharma Inc’s (CUE) share price is $0.71, making it a Sell.
Cue Biopharma Inc’s (CUE) 100-Day exponential moving average is 0.79, while Cue Biopharma Inc’s (CUE) share price is $0.71, making it a Sell.
Cue Biopharma Inc’s (CUE) stock price is $0.71 and Cue Biopharma Inc’s (CUE) 50-day simple moving average is 0.79, creating a Sell signal.
Cue Biopharma Inc’s (CUE) stock price is $0.71 and Cue Biopharma Inc’s (CUE) 100-day simple moving average is 0.75, creating a Sell signal.
Cue Biopharma Inc’s (CUE) stock price is $0.71 and Cue Biopharma Inc’s (CUE) 200-day simple moving average is 0.92, creating a Sell signal.

Cue Biopharma (CUE) Technical Indicators

Sep 29, 2025, 12:02 AM
Name
Value
Implied Action
RSI (14)
41.24
Neutral
STOCH (9,6)
29.01
Neutral
STOCHRSI (14)
26.55
Neutral
MACD (12,26)
-0.03
Buy
ADX (14)
15.57
Buy
Williams %R
-67.80
Buy
CCI (14)
-98.10
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
34.26
Neutral
ROC
-8.97
Sell
Cue Biopharma Inc’s (CUE) Relative Strength Index (RSI) is 41.24, creating a Neutral signal.
Cue Biopharma Inc’s (CUE) Trend Strength Indicator (ADX) is 15.57, creating a Buy signal.
Cue Biopharma Inc’s (CUE) Commodity Channel Index (CCI) is -98.10, creating a Neutral signal.
Cue Biopharma Inc’s (CUE) Price Rate of Change (ROC) is -8.97, creating a Sell signal.

FAQ

Is CUE a Buy, Hold, or Sell?
Based on CUE’s technical indicators, CUE is a Sell.
    What is CUE’s RSI (14)?
    CUE’s RSI (14) is 41.24, which suggests CUE is a Neutral.
      What is CUE’s MACD?
      CUE’s MACD is -0.03, which suggests CUE is a Buy.
        What is CUE’s 5-day moving average?
        CUE’s 5-day moving average is 0.70, which suggests CUE is a Buy.
          What is CUE’s 20-day moving average?
          CUE 20-day moving average is 0.74, which suggests CUE is a Sell.
            What is CUE’s 50-day moving average?
            CUE’s 50-day moving average is 0.79, which suggests CUE is a Sell.
              What is CUE’s 200-day moving average?
              CUE’s 200-day moving average is 0.92, which suggests CUE is a Sell.
                What is CUE’s Williams % R (14)?
                CUE’s Williams % R (14) is -67.80, which suggests CUE is a Buy.
                  What is CUE’s CCI (14)?
                  CUE’s CCI (14) is -98.10, which suggests CUE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis